Molecular (MOLN.SW) traded up 3.63 % during a 24 hours period ending at 03:26 PM Central Europe on Monday 26th. One Molecular stock can currently be bought for about CHF 3.07 on popular exchanges. Current supply of Molecular stocks is 38.3 mn. Molecular has a current market capitalization of CHF 120.3 mn and approximately CHF 11.2 k worth of Molecular was traded on exchanges in the last 24 hours. Since last month end, Molecular has traded -7.65 % down. Simple moving average of last 200 days is at CHF 3.31. The highest price of past 52 weeks was recorded at CHF 3.96 on 03/06/2026. 52 weeks low was at CHF 2.66 on 05/13/2026.

Summary of the latest news for Molecular

Molecular Partners AG has reported a notable improvement in its financial position for the first half of 2026, with a rise in both revenue and net profit compared to the same period last year. The company’s management notes that a significant portion of the gains is attributed to a reduction in government subsidies and a more efficient cost structure. However, analysts point out that the company’s profitability remains sensitive to changes in its core business segments, as recent quarterly results have shown a decline in the performance of key brands. The company continues to monitor cash flow and working‑capital metrics, with recent indicators suggesting a stabilization of receivables and inventory levels. Overall, the update signals a modest rebound in the firm’s earnings while highlighting ongoing challenges within its product portfolio.

Here is how related stocks have performed in the past 24 hours:

  • Multitude (MULT.DE) traded down -1.42 % and now trades at EUR 5.56. Current market capitalisation for Multitude is EUR 119.1 mn. Current price/earnings ratio for Multitude is 5.96. Multitude AG, a listed European fintech group, has announced that its wholly owned subsidiary, Multitude Bank p.l.c., is evaluating a potential issuance of floating‑rate perpetual additional tier 1 capital bonds. The bank has appointed Pareto Securities AB and DNB Carnegie Investment Bank AB as joint bookrunners and will hold a series of fixed‑income investor meetings beginning on 26 October 2026. The meeting series is part of the bank’s assessment of a prospective EUR‑denominated bond issuance. Multitude AG, which offers digital lending and online banking services through its Consumer Banking, SME Banking, and Wholesale Banking units, operates across 17 European countries and employs more than 700 people. The company’s banking subsidiary, licensed in Malta, provides digital banking services to individuals and businesses throughout the European Economic Area.

  • Bebo Health (MLBBO.PA) traded flat 0 % and now trades at EUR 0.17. Current market capitalisation for Bebo Health is EUR 119.3 mn.

  • Varia Us Properties (VARN.SW) traded down -1.74 % and now trades at CHF 11.1. Current market capitalisation for Varia Us Properties is CHF 114.4 mn.

  • Leclanche (LECN.SW) traded flat 0 % and now trades at CHF 0.08. Current market capitalisation for Leclanche is CHF 135.1 mn.

  • Lastminute (LMN.SW) traded down -1.26 % and now trades at CHF 9.12. Current market capitalisation for Lastminute is CHF 99.5 mn. Current price/earnings ratio for Lastminute is 33.11.

About Molecular

Molecular Partners AG is a biotechnology company based in Switzerland that specializes in developing and marketing biopharmaceutical products. The company focuses on creating designed ankyrin repeat protein platform therapies, which are used in various fields such as ophthalmology, oncology, inflammation, and other therapeutic treatments. Molecular Partners serves healthcare professionals and patients globally, and their website is www.molecularpartners.com . They are listed on the SIX Swiss Exchange.